You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TK inhibitor

Showing 1 - 25 of 7,542
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

Recruiting
  • Brain Metastases
  • Non-small Cell Lung Cancer
  • EGFR-TK Inhibitor
  • Stereotactic radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 27, 2023

Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

Recruiting
  • Carcinoma, Adenoid Cystic
  • EGFR-TK Inhibitor
  • Qingdao, Shandong, China
    Qingdao central Hospital
Nov 1, 2021

Glioma, Malignant Trial in United States (biological, drug, radiation, other)

Active, not recruiting
  • Glioma, Malignant
  • AdV-tk
  • +5 more
  • Los Angeles, California
  • +7 more
Jan 30, 2023

Non Small Cell Lung Cancer Trial in United States (Aglatimagene besadenovec)

Recruiting
  • Non Small Cell Lung Cancer
  • Aglatimagene besadenovec
  • Farmington, Connecticut
  • +10 more
Mar 28, 2022

Mucositis Trial in India (TK-112690, Placebo)

Recruiting
  • Mucositis
  • Srinagar, Jammu & Kashmir, India
  • +4 more
Dec 12, 2022

EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

Terminated
  • EGFR Activating Mutation
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 28, 2021

Mucositis Trial in India (TK-112690, Placebo)

Recruiting
  • Mucositis
  • Bhopal, Madhya Pradesh, India
  • +4 more
Dec 19, 2022

Pharmacological Action Trial (Ulinastatin, saline)

Not yet recruiting
  • Pharmacological Action
  • (no location specified)
Sep 6, 2022

Tranexamic Acid for Angiotensin-converting Enzyme

Completed
  • Angioedema
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    Personalised Disease Monitoring in Metastatic Breast Cancer

    Recruiting
    • Breast Cancer Metastatic
    • Estrogen Receptor-positive Breast Cancer
      • Gothenburg, Sweden
      • +6 more
      Dec 7, 2022

      Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

      Not yet recruiting
      • Diabetes Mellitus
      • +2 more
      • Seoul, Korea, Republic of
        Yonsei University College of Medicine
      Aug 1, 2023

      Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

      Suspended
      • Metastatic Malignant Solid Neoplasm
      • +3 more
      • Boston, Massachusetts
        Dana-Farber - Harvard Cancer Center LAO
      Sep 17, 2022

      Healthy Trial in Germany (TK-254RX)

      Not yet recruiting
      • Healthy
      • Brühl, Germany
      • +3 more
      Sep 14, 2023

      Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

      Not yet recruiting
      • Malignant Solid Neoplasm
      • +4 more
      • (no location specified)
      Nov 8, 2022

      Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)

      Not yet recruiting
      • Metastatic Breast Cancer
      • Unresectable Breast Cancer
      • DiviTum® TKa assay
      • CDK4/6 + Endocrine therapy
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 27, 2023

      Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

      Not yet recruiting
      • Adenocarcinoma of Lung
      • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Jul 8, 2022

      Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)

      Not yet recruiting
      • Breast Neoplasm
      • (no location specified)
      May 8, 2023

      NSCLC Trial in Worldwide (Erlotinib, Docetaxel)

      Completed
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • Wien, Austria
      • +31 more
      Aug 23, 2022

      Breast Tumor Trial in Mainz (Palbociclib, Fulvestrant, Anastrozole)

      Terminated
      • Breast Neoplasm
      • Mainz, Germany
        University Hospital Mainz
      Dec 16, 2021

      Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)

      Completed
      • Metastatic Renal Cell Carcinoma
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale Tumori
      Apr 23, 2021

      Two Swept Source Optical Coherence Tomography Biometers

      Completed
      • Cataract
      • Argos
      • IOLMaster 700
      • Frankfort, Illinois
        Multack Eye Care
      Feb 17, 2023

      Accuracy of IOLMASTER 700 Total Keratometry (TK)

      Recruiting
      • Myopia
      • +2 more
      • IOLMASTER 700 TK
      • Los Angeles, California
      • +4 more
      Feb 15, 2022

      Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

      Recruiting
      • Metastatic Clear Cell Renal Carcinoma
      • CT scan
      • Plasma collection
      • Milan, Mi, Italy
        Istituto Tumori
      Mar 13, 2023

      Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta

      Terminated
      Has Results
      • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Atlanta, Georgia
        Emory University/Winship Cancer Institute
      Dec 19, 2018

      Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

      Active, not recruiting
      Has Results
      • Metastatic Non-small Cell Lung Cancer
      • Metastatic Triple-negative Breast Cancer
      • ADV/HSV-tk
      • +3 more
      • Houston, Texas
        Houston Methodist Cancer Center
      Dec 28, 2022